Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...

The initiative is expected to assist the Company in organizing and evaluating a growing body of research data, including formulation records, ingredient studies, and scientific publications related to ...

Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ: WNW) announced today that the Company is introducing a strategic artificial ...

India talent pool attracting GCCs The GCC Innovation Acceleration Programme aims to support more than 50 companies in scaling their operation in India NTT DATA has announced the launch of its GCC Inno ...

HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that Broadway Colours Ltd. has earned certification as a qualified HydroGraph Compounding Partner ...

What is leadership, at its core? It is the effective stewardship of long-term institutional destiny. This attention to stewardship defines the difference between managers and visionaries. Managers ...

Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application (ANDA).FDA has ...

Crystec Limited (CrystecPharma) is delighted to announce a strategic partnership with Joel Hi-Tech, China’s leading supercritical fluid extraction technology company. By combining Joel Hi-Tech’s ...

Bel Group’s Anne Pitkowski reveals how AI, virtual twins, and precision fermentation are transforming cheese innovation, sustainability, and product development.

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and WuXi Biologics (2269.HK), a global leading Contract Research, Development and ...

Researchers developed compilation-based quantum process tomography, a framework that reconstructs quantum operations using fewer measurements than conventional methods.

Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2025 Earnings Call Transcript March 16, 2026 Assertio Holdings, Inc. beats earnings expectations. Reported EPS is $-1.72227, expectations were $-3.1225.